Intermittent Fasting and Super food Diet may help non alcoholic fatty liver Disease (NAFLD)
Phase 3
- Conditions
- Health Condition 1: E889- Metabolic disorder, unspecified
- Registration Number
- CTRI/2024/04/065699
- Lead Sponsor
- IVERSITY GRANTA COMMISSION NFOBC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult age group (18-65 years)
- Diagnosed with NAFLD by physicians.
- A valid consent
Exclusion Criteria
-NAFLD patients with cirrhosis or hepatocellular carcinoma
- Pregnant and lactating lady.
- People with other causes of liver disease will be excluded (alcohol, viral, genetic,
hepatic viruses A-E, etc.).
- Patients who consume more than 20 g of alcohol per day (10 g per day in men)
- Those on drugs that can induce fatty liver or insulin sensitization, such as estrogens,
amiodarone, methotrexate, tamoxifen, glitazones, and metformin, were also excluded
from the study.
- Bedridden individuals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of hepatic steatosis (steatohepatitis) as measured by a fibroscan and USG abdomenTimepoint: Within 6 months
- Secondary Outcome Measures
Name Time Method Get knowledge about the importance of indigenously available superfoods and their rational uses, as well as their impact on the bodyTimepoint: in 3 years Through out study;Reduction of inflammation (via liver enzyme reduction); reduction of fibrosis (via fibro-scan decrease in liver stiffness)Timepoint: Within 6 months after interventions given